UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020106
Receipt number R000023223
Scientific Title usefulness of cold snare polypectomy for patients taking novel oral anticoagulant and warfarin
Date of disclosure of the study information 2015/12/07
Last modified on 2020/12/15 05:26:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

usefulness of cold snare polypectomy for patients taking novel oral anticoagulant and warfarin

Acronym

usefulness of cold snare polypectomy for patients taking novel oral anticoagulant and warfarin

Scientific Title

usefulness of cold snare polypectomy for patients taking novel oral anticoagulant and warfarin

Scientific Title:Acronym

usefulness of cold snare polypectomy for patients taking novel oral anticoagulant and warfarin

Region

Japan


Condition

Condition

colorectal polyp

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the usefulness and safeness of cold snare polypectomy for colorectal polyps in patients who are prescribed NOAC or warfarin.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

late bleeding(within 2 weeks after procedure)

Key secondary outcomes

early bleeding; adverse events other than bleeding; rate of complete resection


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

To perform cold snare polypectomy for colorectal polyps in patients taking NOAC.

Interventions/Control_2

To perform cold snare polypectomy for colorectal polyps in patients taking warfarin.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

1.patients with colorectal polyps who are going to receive endoscopic resection.
2.the polyp is no larger than 10mm, not suspected of high grade or early cancer, and not Ip in morphology.
3.patietns who are taking NOAC or warfarin.
4.NOAC includes dabigatran, rivaroxaban , apixaban, and edoxaban.

Key exclusion criteria

1.combination use of antiplatelet agents.
2.history of inflammatory bowel disease.
3.Patients with severe heart failure, renal failure, psychiatric disorder, liver failure.
4.pregnancy

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takuma
Middle name
Last name Higurashi

Organization

Yokohama City University school of medicine

Division name

Department of gastroenterology and hepatology

Zip code

236-0004

Address

3-9 Fukuura Kanazawa-ku Yokohama City

TEL

045-787-2640

Email

takma_h@yokohama-cul.ac.jp


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Higurashi

Organization

Yokohama City University School of Medicine

Division name

Department of Gastroenterology and Hepatorogy

Zip code

236-0004

Address

3-9 Fukuura Kanazawa-ku Yokohama City

TEL

045-787-2640

Homepage URL


Email

takuma_h@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama CIty University School of Medicine Department of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University Hospital IRB

Address

3-9 Fukuura Kanazawa-ku Yokohama City

Tel

045-787-2640

Email

umezawa-ykh@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属病院


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

90

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Delay of analysis

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 12 Month 01 Day

Date of IRB

2015 Year 12 Month 10 Day

Anticipated trial start date

2015 Year 12 Month 10 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2019 Year 06 Month 30 Day

Date analysis concluded

2019 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 12 Month 07 Day

Last modified on

2020 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023223